These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16880406)

  • 1. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.
    Myung SJ; Rerko RM; Yan M; Platzer P; Guda K; Dotson A; Lawrence E; Dannenberg AJ; Lovgren AK; Luo G; Pretlow TP; Newman RA; Willis J; Dawson D; Markowitz SD
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12098-102. PubMed ID: 16880406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
    Yan M; Rerko RM; Platzer P; Dawson D; Willis J; Tong M; Lawrence E; Lutterbaugh J; Lu S; Willson JK; Luo G; Hensold J; Tai HH; Wilson K; Markowitz SD
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17468-73. PubMed ID: 15574495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.
    Yan M; Myung SJ; Fink SP; Lawrence E; Lutterbaugh J; Yang P; Zhou X; Liu D; Rerko RM; Willis J; Dawson D; Tai HH; Barnholtz-Sloan JS; Newman RA; Bertagnolli MM; Markowitz SD
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9409-13. PubMed ID: 19470469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of experimental colon cancer by genistein.
    Rao CV; Wang CX; Simi B; Lubet R; Kelloff G; Steele V; Reddy BS
    Cancer Res; 1997 Sep; 57(17):3717-22. PubMed ID: 9288778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
    Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
    Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
    Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
    Cancer Res; 2002 Jan; 62(1):28-32. PubMed ID: 11782353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
    Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
    Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells.
    Mehdawi LM; Prasad CP; Ehrnström R; Andersson T; Sjölander A
    Mol Oncol; 2016 Nov; 10(9):1415-1429. PubMed ID: 27522468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
    Tai HH; Chi X; Tong M
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
    Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Hahm KB
    Int J Cancer; 2016 Mar; 138(6):1482-93. PubMed ID: 26476372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.
    Wang QS; Papanikolaou A; Sabourin CL; Rosenberg DW
    Carcinogenesis; 1998 Nov; 19(11):2001-6. PubMed ID: 9855016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.
    Choi SH; Kim BG; Robinson J; Fink S; Yan M; Sporn MB; Markowitz SD; Letterio JJ
    J Clin Invest; 2014 Jun; 124(6):2472-82. PubMed ID: 24837432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
    Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A
    Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats.
    Zhang Y; Li Q; Zhou D; Chen H
    Br J Nutr; 2013 Jan; 109(1):33-42. PubMed ID: 22716201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.
    Torlakovic EE; Keeler V; Wang C; Lim HJ; Lining LA; Laferté S
    BMC Cancer; 2009 Jul; 9():251. PubMed ID: 19627619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent susceptibility to azoxymethane-induced and spontaneous tumorigenesis in the Min/+ mouse.
    Paulsen JE; Steffensen IL; Namork E; Eide TJ; Alexander J
    Anticancer Res; 2003; 23(1A):259-65. PubMed ID: 12680222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.